Published in J Heart Lung Transplant on February 01, 2004
Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res (2008) 1.80
The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ Res (2011) 1.64
Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat Rev Immunol (2015) 1.22
Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ Res (2015) 1.05
Innate immunity and cardiomyocytes in ischemic heart disease. Life Sci (2014) 1.02
Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice. PLoS One (2012) 0.94
Therapeutic targeting of innate immunity in the failing heart. J Mol Cell Cardiol (2010) 0.89
Innate immunity in the adult mammalian heart: for whom the cell tolls. Trans Am Clin Climatol Assoc (2010) 0.87
NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis. PLoS One (2012) 0.86
MicroRNA involvement in immune activation during heart failure. Cardiovasc Drugs Ther (2011) 0.84
Toll-like receptors 2 and 4 modulate autonomic control of heart rate and energy metabolism. Brain Behav Immun (2013) 0.83
The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly. Heart Fail Rev (2012) 0.82
Conditional knockout of prolyl hydroxylase domain protein 2 attenuates high fat-diet-induced cardiac dysfunction in mice. PLoS One (2014) 0.81
Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction. J Cell Mol Med (2015) 0.81
TLR4 Expression Is Associated with Left Ventricular Dysfunction in Patients Undergoing Coronary Artery Bypass Surgery. PLoS One (2015) 0.79
Retinol-Binding Protein 4 Induces Cardiomyocyte Hypertrophy by Activating TLR4/MyD88 Pathway. Endocrinology (2016) 0.78
The role of B-cells in heart failure. Methodist Debakey Cardiovasc J (2013) 0.75
Beneficial Effects of Qili Qiangxin Capsule on Lung Structural Remodeling in Ischemic Heart Failure via TGF-β1/Smad3 Pathway. Evid Based Complement Alternat Med (2015) 0.75
Age has a role in driving host immuno-pathological response to alphavirus infection. Immunology (2017) 0.75
Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med (2006) 8.98
Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J (2004) 7.84
Truncations of titin causing dilated cardiomyopathy. N Engl J Med (2012) 6.07
Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation (2011) 3.18
Hereditary fibrinogen A alpha-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantation. Blood (2009) 2.30
Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model. Circulation (2007) 2.24
Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol (2011) 2.22
A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med (2008) 2.10
Cardiac allograft vasculopathy after heart transplantation: electrocardiographically gated cardiac CT angiography for assessment. Radiology (2013) 2.04
Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function. Nature (2011) 1.98
Long-term outcomes after autograft versus homograft aortic root replacement in adults with aortic valve disease: a randomised controlled trial. Lancet (2010) 1.95
Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol (2009) 1.85
Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol (2013) 1.84
Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J (2006) 1.78
The cardiac valve interstitial cell. Int J Biochem Cell Biol (2003) 1.76
Role of human valve interstitial cells in valve calcification and their response to atorvastatin. Circulation (2006) 1.75
Late outcomes following freestyle versus homograft aortic root replacement: results from a prospective randomized trial. J Am Coll Cardiol (2010) 1.72
Clinical, molecular, and genomic changes in response to a left ventricular assist device. J Am Coll Cardiol (2011) 1.69
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J (2011) 1.67
Cellular and molecular mechanisms of thoracic aortic aneurysms. Nat Rev Cardiol (2009) 1.65
The Ross procedure: a systematic review and meta-analysis. Circulation (2008) 1.65
Myocardial sympathetic innervation and long-term left ventricular mechanical unloading. JACC Cardiovasc Imaging (2010) 1.61
Depression and perceptions about heart failure predict quality of life in patients with advanced heart failure. Heart Lung (2010) 1.58
Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng (2006) 1.57
Trends in long-term mechanical circulatory support for advanced heart failure in the UK. Eur J Heart Fail (2013) 1.57
Establishing pediatric cardiovascular services in the developing world: a wake-up call. Circulation (2007) 1.54
Acute mycophenolate overdose: case series and systematic literature analysis. Expert Opin Drug Saf (2014) 1.48
Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res (2006) 1.47
Reversible sirolimus-associated pneumonitis after heart transplantation. J Heart Lung Transplant (2005) 1.47
Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures. J Thorac Cardiovasc Surg (2007) 1.45
Multigene adenoviral therapy for the attenuation of ischemia-reperfusion injury after preservation for cardiac transplantation. J Thorac Cardiovasc Surg (2003) 1.43
Bridge to recovery: what remains to be discovered? Cardiol Clin (2011) 1.42
Development of an in vivo ischemia-reperfusion model in heterotopically transplanted rat hearts. Transplantation (2002) 1.40
ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med (2002) 1.39
Preserved homograft function 32 years after surgery in a young patient. J Thorac Cardiovasc Surg (2010) 1.38
Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J (2004) 1.38
Single fibers of skeletal muscle as a novel graft for cell transplantation to the heart. J Thorac Cardiovasc Surg (2002) 1.37
Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis (2005) 1.36
Cardiac transplantation for amyloid heart disease: the United Kingdom experience. J Heart Lung Transplant (2004) 1.36
Nano-analytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat Mater (2013) 1.34
Neglected tropical cardiomyopathies: II. Endomyocardial fibrosis: myocardial disease. Heart (2008) 1.29
Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. Cardiovasc Res (2008) 1.28
Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant (2010) 1.27
Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood (2004) 1.26
The structure and function of cardiac t-tubules in health and disease. Proc Biol Sci (2011) 1.23
Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun (2007) 1.23
Comparison of techniques for the measurement of left ventricular function following cardiac transplantation. J Cardiovasc Magn Reson (2002) 1.19
Bridge to recovery with the use of left ventricular assist device and clenbuterol. Ann Thorac Surg (2003) 1.17
Cytoskeletal protein 4.1R affects repolarization and regulates calcium handling in the heart. Circ Res (2008) 1.17
Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg (2007) 1.17
The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells. Biomaterials (2012) 1.16
Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation. J Thorac Cardiovasc Surg (2012) 1.15
Genetic background affects function and intracellular calcium regulation of mouse hearts. Cardiovasc Res (2010) 1.15
Heat shock protein 72 enhances manganese superoxide dismutase activity during myocardial ischemia-reperfusion injury, associated with mitochondrial protection and apoptosis reduction. Circulation (2002) 1.15
Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. Eur Heart J (2004) 1.13
Towards clinical molecular diagnosis of inherited cardiac conditions: a comparison of bench-top genome DNA sequencers. PLoS One (2013) 1.12
Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation (2004) 1.12
Gene profiling changes in cytoskeletal proteins during clinical recovery after left ventricular-assist device support. Circulation (2005) 1.10
Neglected diseases in cardiology: a call for urgent action. Nat Clin Pract Cardiovasc Med (2008) 1.10
Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis. Circulation (2006) 1.10
Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds-relevance to tissue engineering. Tissue Eng (2006) 1.10
Contemporary use of ventricular assist devices. Annu Rev Med (2010) 1.09
The role of bridge to transplantation: should LVAD patients be transplanted? Curr Opin Cardiol (2004) 1.09
Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci U S A (2004) 1.08
Limited utility of endomyocardial biopsy in the first year after heart transplantation. Transplantation (2008) 1.08
Targeted cell delivery into infarcted rat hearts by retrograde intracoronary infusion: distribution, dynamics, and influence on cardiac function. Circulation (2004) 1.08
Mechanical unloading reverses transverse tubule remodelling and normalizes local Ca(2+)-induced Ca(2+)release in a rodent model of heart failure. Eur J Heart Fail (2012) 1.08
Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heart. Circ Res (2011) 1.07
Expression of follistatin-related genes is altered in heart failure. Endocrinology (2008) 1.07
European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg (2009) 1.07
Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling. Am J Pathol (2013) 1.07
Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells. Tissue Eng Part A (2009) 1.06
30-year outcome of anatomic correction of anomalous origin of the left coronary artery from the pulmonary artery. J Am Coll Cardiol (2011) 1.06
Upgrade ambulatory extra-aortic counterpulsation to full-support LVAD. JACC Heart Fail (2015) 1.05
Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J (2004) 1.04
Prolonged mechanical unloading affects cardiomyocyte excitation-contraction coupling, transverse-tubule structure, and the cell surface. FASEB J (2010) 1.04
Up-regulation of c-jun mRNA in cardiac myocytes requires the extracellular signal-regulated kinase cascade, but c-Jun N-terminal kinases are required for efficient up-regulation of c-Jun protein. Biochem J (2002) 1.04
Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation (2008) 1.04